Edition:
United States

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

3.60USD
11:53am EST
Change (% chg)

$-0.13 (-3.49%)
Prev Close
$3.73
Open
$3.75
Day's High
$3.80
Day's Low
$3.58
Volume
18,059
Avg. Vol
80,024
52-wk High
$12.98
52-wk Low
$2.76

Chart for

About

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which... (more)

Overall

Beta: --
Market Cap(Mil.): $86.72
Shares Outstanding(Mil.): 17.63
Dividend: --
Yield (%): --

Financials

  ZYNE.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.88 -- --
ROI: -62.66 0.60 13.80
ROE: -62.66 -2.18 15.29

Earnings vs. Estimates